Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
BMC Cancer
|
May 23, 2022
A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial
Jacques Balosso, Olivia Febvey-Combes, Annie Iung, et al.
European Urology
|
August 15, 2025
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial
Nicolas Demogeot, Paul Sargos, Julia Salleron, et al.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 24, 2024
Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE
Cecile Evin, Laurent Quéro, Karine Le Malicot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 22, 2023
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE
Véronique Vendrely, Claire Lemanski, Pascal Pommier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 8, 2024
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines
Raquel Dávila Fajardo, Giovanni Scarzello, Mark N Gaze, et al.
European Urology
|
October 1, 2025
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical Trial
Amar U Kishan, Jesus E Juarez Casillas, Paul Sargos, et al.
European Urology Oncology
|
April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
Nicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
European Urology
|
June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
Sarah Burdett, David J Fisher, Jayne F Tierney, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus
Simon K B Spohn, Cédric Draulans, Amar U Kishan, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
BMC Cancer
|
May 23, 2022
A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial
Jacques Balosso, Olivia Febvey-Combes, Annie Iung, et al.
European Urology
|
August 15, 2025
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial
Nicolas Demogeot, Paul Sargos, Julia Salleron, et al.
Clinical and Translational Radiation Oncology
|
March 27, 2023
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Maximilien Rogé, Yoann Pointreau, Paul Sargos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 24, 2024
Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE
Cecile Evin, Laurent Quéro, Karine Le Malicot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 22, 2023
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE
Véronique Vendrely, Claire Lemanski, Pascal Pommier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 8, 2024
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines
Raquel Dávila Fajardo, Giovanni Scarzello, Mark N Gaze, et al.
European Urology
|
October 1, 2025
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical Trial
Amar U Kishan, Jesus E Juarez Casillas, Paul Sargos, et al.
European Urology Oncology
|
April 14, 2023
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
Nicolas Benziane-Ouaritini, Thomas Zilli, Antoine Giraud, et al.
European Urology
|
June 26, 2025
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data
Sarah Burdett, David J Fisher, Jayne F Tierney, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus
Simon K B Spohn, Cédric Draulans, Amar U Kishan, et al.
Page
of 12